⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for reqorsa

Every month we try and update this database with for reqorsa cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on OsimertinibNCT04486833
Carcinoma, Non-...
quaratusugene o...
osimertinib
Platinum-Based ...
18 Years - Genprex, Inc.
Quaratusugene Ozeplasmid (Reqorsa) in Combination With Pembrolizumab in Previously Treated Non-Small Lung CancerNCT05062980
Non Small Cell ...
quaratusugene o...
pembrolizumab
docetaxel
ramucirumab
Investigator's ...
18 Years - Genprex, Inc.
Quaratusugene Ozeplasmid (Reqorsa) in Combination With Pembrolizumab in Previously Treated Non-Small Lung CancerNCT05062980
Non Small Cell ...
quaratusugene o...
pembrolizumab
docetaxel
ramucirumab
Investigator's ...
18 Years - Genprex, Inc.
Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC PatientsNCT05703971
Small Cell Lung...
quaratusugene o...
atezolizumab
18 Years - Genprex, Inc.
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on OsimertinibNCT04486833
Carcinoma, Non-...
quaratusugene o...
osimertinib
Platinum-Based ...
18 Years - Genprex, Inc.
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: